AGIOS PHARMACEUTICALS, INC. (AGIO) › Cost of RevenueAGIOS PHARMACEUTICALS, INC. (AGIO) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $02017: $02018: $1.40M2019: $1.32M2020: $02021: $02022: $1.70M2023: $2.88M2024: $4.17M2025: $6.34M$6.34M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$6.34M+52.3%2024$4.17M+44.6%2023$2.88M+69.1%2022$1.70M—2021$0—2020$0-100.0%2019$1.32M-5.7%2018$1.40M—2017$0—2016$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share